University of Texas Southwestern Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).
University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.
University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.
Top-decile sponsor footprint
University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
837 total, page 9 of 17
Efficacy of Ocrelizumab in Autoimmune Encephalitis
NCT03835728
Treatment of Foot and Leg Ulcers Using a Laser
NCT03955289
Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer
NCT03649321
Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate
NCT03812380
Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer
NCT03747042
Problem Solving Training for Care Partners of Adults With Traumatic Brain Injury
NCT03739450
GrafixPL PRIME Evaluation Case Study
NCT03742440
Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]
NCT03686566
Evaluation of Prophylactic Endotracheal Intubation
NCT03716466
Pet Ownership and Glucose Control in Early Adolescents With Type 1 Diabetes
NCT03761251
IVIG (Gamunex-C) Treatment Study for POTS Subjects
NCT03919773
Alteration of Stool Microbiota in Preterm Infants With Anemia
NCT03554278
SAbR For Oligo-Progressive Renal Cell Cancer.
NCT03696277
Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway
NCT03480594
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
NCT03706742
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
NCT03414125
A Probiotic Intervention to Prevent Relapse Following Hospitalization for Mania
NCT03383874
A Neurosteroid Intervention for Menopausal and Perimenopausal Depression
NCT03505905
Geographically Clustered Mailing of Fecal Immunochemical Test (FIT) Kits
NCT03718221
7T Magnetic Resonance Spectroscopy and Skeletal Muscle Biopsy Findings in Statin Associated Adverse Muscle Events
NCT04507373
Influence of Early Menopause on Sympathetic Activation and Cardiovascular Function in Older Women
NCT03692572
Therapeutic Drug Monitoring of Cardiac Medications
NCT03667781
Sildenafil Treatment for Mild TBI
NCT03598140
Obesity and OSA in Pregnancy
NCT05654259
Using Hyperpolarized [1-13C]Pyruvate to Detect Cardiotoxicity
NCT03685175
Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal
NCT04112160
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression
NCT03191058
Radiofrequency and Hybrid Fractional Laser for Vaginal Rejuvenation
NCT03316950
Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D
NCT03301532
Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Ketamine
NCT03621085
Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer
NCT03548285
Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
NCT03135249
UTSW HP [13-C] Pyruvate Injection in HCM
NCT03057002
Percutaneous Screw Fixation vs. Open Fixation in the Treatment of Thoracolumbar Fractures
NCT04495400
Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)
NCT03181399
Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)
NCT03354143
Harms of Hepatocellular Carcinoma Surveillance
NCT03756051
Patient Mobility and Outcomes After Cardiac Surgery
NCT03806257
Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5
NCT02582918
Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO
NCT03318393
Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)
NCT03095612
Radio Frequency Microneedling for Suprapatellar Skin
NCT03507036
The Use of High Flow Nasal Cannula, Standard Face Mask and Standard Nasal Cannula in Morbidly Obese Patients
NCT03479905
Physiological Study of the Efficacy and Mechanistic Effects of Alcohol Renal Denervation
NCT03465917
Role of Axumin PET Scan in Germ Cell Tumor
NCT03426865
Improving Sleep Quality in Flap Patients in the SICU
NCT03957317
High Intensity Exercise for Increasing Fitness in Patients With Hypertrophic Cardiomyopathy
NCT03335332
The Perioperative Management of Anti-thrombotic Drug Registry
NCT03695159
Pilot Intervention for Social Biases in Eating Disorders
NCT04877158
Foley Bulb With Oral Misoprostol for Induction of Labor
NCT03407625
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 106 |
| Phase 2 | 122 |
| Phase 3 | 28 |
| Phase 4 | 98 |
Therapeutic Areas
What is open in the University of Texas Southwestern Medical Center pipeline
162 recruiting of 837 indexed (19% open); 503 completed (60%).
Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Hypertension (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas Southwestern Medical Center: open-pipeline peers nationwide
Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 837 trials (± recruiting share)
- University of Utah · 818 trials · 17% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Indiana University · 890 trials · 18% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- California Polytechnic State University-San Luis Obispo · 19% recruiting · 26 trials
- Phoenix Children's Hospital · 19% recruiting · 26 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- Vanderbilt University Medical Center · 19% recruiting · 677 trials
Related
What to do with this University of Texas Southwestern Medical Center page
837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.
- 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.